SSAC 2010 Meeting Scientific Programme Stockholm Sweden

The SSAC (Scandinavian Society for Antimicrobial Chemotherapy) 27th Annual Meeting 

30 September - 3 October 2008.

Stockholm Sweden

 

Thursday September 30, 2010

15.00-19.00 Minicourse: Fungal infections, diagnostics and treatment.

Chair: Lena Klingspor, SE, Maiken Cavling Arendrup, DK

15.00 Introduction to fungi. Classification and taxonomy, Maiken Cavling Arendrup

15.45 Invasive fungal infections, Malcolm Richardsson, FI

16.30 Coffee break

16.45 Diagnostics of invasive infections, Lena Klingspor

17.30 Antimycotics and Susceptibility testing, Per Sandven, NO

18.15 Treatment of invasive infection, Jan Sjölin, SE

 

Friday October 1, 2010

14.00-15.30 Session 1: ICU-infections

Chair: Carl Spindler, SE, Karl Kristinsson, IC

14. 00 Which bacterial findings should lead to enforced infection control measures in the ICU? Didier Pittet, CH

14.30 Spread of multi-resistant bacteria and infection control in the neonatal intensive care unit, Siren Rettedal, NO

14.45 Etiology of ventilator-associated pneumonia - which samples should be taken and what do we find? Mats Kalin, SE

15.00 Empirical treatment of ventilator-associated pneumonia, Henrik Schönheyder, DK

15.15 The success of ECMO for treatment of severe H1N1-associated pneumonia, Kenneth Palmér, SE

 

Saturday October 2, 2010

09.25-10.15 Session 2: Emerging viral infections

Chair: Maria Rotzén Östlund, SE, Terho Heikkinen, FI

09.25 The pandemic virus of 2009, Annika Linde, SE

09.50 Emerging hemorrhagic fever, Anti Vaheri, FI

 

Saturday October 2, 2010

10.45-12.00 Session 3: Malaria update

Chair: Anna Färnert, SE, Lars Østergård, DK

10.45 Pathogenesis of malaria and vaccine update, Mats Wahlgren, SE

11.05 Lates news in diagnosis and treatment of malaria, Jurgen Kurtzhals, DK

11.25 Changing malaria epidemiology – what are the risks today? Christine Mørch, NO

11.45 If it is not malaria – what is it? Helena Hervius-Askling, SE

 

Saturday October 2, 2010

13.00-14.30 Session 4: Chronic HCV infections – optimized treatment today and tomorrow

Chair: Ola Weiland, SE, Olav Dalgard, NO

13.00 Kinetic-guided standard of care treatment today, Ola Weiland, SE

13.20 Individualized kinetic-guided treatment, Magnus Lindh, SE

13.35 Protease and polymerase inhibitors, Henrik Krarup, DK

13.55 Resistance to protease and polymerase inhibitors, Stefan Zeuzem, GE

14.15 HCV-treatment among intravenous drug users, Olav Dalgard, NO

 

Saturday October 2, 2010

15.45-17.10 Session 5: New vaccines

Chair: Matti Sällberg, SE, Anu Kantele, FI

15.45 Mycobacterium tuberculosis, Markus Maeurer, SE

16.05 Streptococcus pneumoniae, Birgitta Henriques Normark, SE

16.25 Influenza, Bjørn Iversen, NO

16.45 HIV – a critical review of current data, Jens Lundgren, DK

 

Sunday October 3, 2010

09.00-10.15 and 10.45-11.45 Session 6 (interactive): Optimal treatment of critically ill patients

Chair: Christian Giske, SE, Johan Petersson, SE

09.00 Introduction, Christian Giske/Johan Petersson, SE

09.05 Case presentation, Carl Spindler, SE

09.15 Pharmacokinetics in critically ill patients, Niels Frimodt Møller, DK

09.25 Case presentationm Carl Spindler

09.35 Immune response in critically ill patients, Hannu Syrjälä, FI

09.45 Case presentation, Carl Spindler

09.55 Are the commonly used pharmacodynamic targets appropriate for critically ill patients? Alasdair MacGowan, UK

10.15 Coffee break

10.45 Case presentation, Carl Spindler

10.55 Which doses are usually given in Scandinavian ICUs? Jenny Dahl Knudsen, DK and Inga Odenholt, SE

11.05 Case presentation, Carl Spindler

11.15 Which serum concentrations are we obtaining with our current dosing regimes? Johan Petersson

11.25 Panel discussion, Jenny Dahl Knudsen, Inga Odenholt, Hannu Syrjäla, Truls Leegård, NO, Magnus Gottfredsson, IC, Alasdair MacGowan

11.40 Closing remarks Christian Giske/Johan Petersson